Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 1,001–1,100 of 3,349
Bo, W., Cheng, G., Bi, Q., Lu, C. C., Sun, Q., Li, L., Chen, N., Hu, M., Lu, H., Xu, X., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.07.011 · Cited by 54
Le Page, A., Lamoureux, J., Bourgade, K., Frost, E. H., Pawelec, G., Witkowski, J. M., Larbi, A., Dupuis, G., & Fülöp, T. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170124 · Cited by 41
“For instance, it has been shown that C1q is present in the vicinity of amyloids plaques [91], that complement intermediates have been identified by Genome-Wide Association Studies [92] and, that a link has been proposed between and microglial synapse loss [93, 94].”
Cao, K., Xiang, J., Dong, Y., Xu, Y., Li, Y., Song, H., Zeng, X.-X., Ran, L., Hong, W., & Guan, Z.-Z. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0490-3 · Cited by 40
Olsen, A. L., & Feany, M. Β. (2019) · Glia · doi:10.1002/glia.23671 · Cited by 60
Pang, J., Hou, J., Zhou, Z., Ren, M., Mo, Y., Yang, G., Qu, Z., & Hu, Y. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08591-6 · Cited by 42
Posttranslational modifications define course of prion strain adaptation and disease phenotype
Makarava, N., Chang, J. C., Molesworth, K., & Baskakov, I. V. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138677 · Cited by 43
Neuroprotective versus Neuroinflammatory Roles of Complement: From Development to Disease
Kanmogne, M., & Klein, R. S. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.003 · Cited by 42
Tajbakhsh, A., Read, M., Barreto, G. E., Ávila-Rodriguez, M., Gheibi-Hayat, S. M., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41
An emerging role for microglia in stress‐effects on memory
Sanguino‐Gómez, J., Buurstede, J. C., Abiega, O., Fitzsimons, C. P., Lucassen, P. J., Eggen, B. J. L., Lesuis, S. L., Meijer, O. C., & Krugers, H. J. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15188 · Cited by 49
“Moreover, microglia have been shown to mediate synaptic loss in Alzheimer models (Hong et al., 2016) and to show distinct patterns of activation in response to amyloid and tau in Alzheimer's disease (Gerrits et al., 2021).”
BackgroundTakata, K., Ginhoux, F., & Shimohama, S. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114754 · Cited by 45
Li, T., Yu, D., Oak, H. C., Zhu, B., Wang, L., Jiang, X., Molday, R. S., Kriegstein, A., & Piao, X. (2021) · The EMBO Journal · doi:10.15252/embj.2021107915 · Cited by 42
“…removal contributes to neuropsychiatric disorders such as autism spectrum disorder and schizophrenia (Tang et al , 2014; Sekar et al , 2016; Sellgren et al , 2019), whereas aberrant re-activation of synaptic elimination later in life may underlie Alzheimer’s disease pathology (Hong et al , 2016).”
Navakkode, S., Gaunt, J. R., Pavón, M. V., Bansal, V. A., Abraham, R. P., Chong, Y. S., Ch’ng, T. H., & Sajikumar, S. (2021) · Aging Cell · doi:10.1111/acel.13502 · Cited by 44
Microglia Drive Pockets of Neuroinflammation in Middle Age
Moca, E. N., Lecca, D., Hope, K. T., Etienne, F., Schaler, A. W., Espinoza, K., Chappell, M. S., Gray, D. T., Tweedie, D., Sidhu, S., et al. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1922-21.2022 · Cited by 42
Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
Zhao, Y., Liu, B., Wang, J., Xu, L., Yu, S., Fu, J., Yan, X., & Su, J. (2022) · Biomedicines · doi:10.3390/biomedicines10081800 · Cited by 53
“Before the formation of plaques in AD, microglia play a role in promoting early synaptic loss and dysfunction [9].”
BackgroundMicroglia: Synaptic modulator in autism spectrum disorder
Hu, C., Li, H., Li, J., Luo, X., & Hao, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.958661 · Cited by 60
LilrB3 is a putative cell surface receptor of APOE4
Zhou, J., Wang, Y., Huang, G., Yang, M., Zhu, Y., Jin, C., Jing, D., Ji, K., & Shi, Y. (2023) · Cell Research · doi:10.1038/s41422-022-00759-y · Cited by 52
Fan, J., Dong, X., Tang, Y., Wang, X., Lin, D., Gong, L., Chen, C., Jiang, J., Shen, W., Xu, A., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14224 · Cited by 51
Zhou, R., Chen, S., Zhao, Z., Tu, D., Song, S., Wang, Y., Wang, Q., Feng, J., & Hong, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03393-w · Cited by 46
Li, R., Wang, J., Xiong, W., Luo, Y., Feng, H., Zhou, H., Peng, Y., He, Y., & Ye, Q. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1358179 · Cited by 58
Microglial cGAS–STING signaling underlies glaucoma pathogenesis
Liu, Y., Wang, A., Chen, C., Zhang, Q., Shen, Q., Zhang, D., Xiao, X., Chen, S., Lian, L., Le, Z., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409493121 · Cited by 57
“Microglia and monocyte - derived cells, functioning as immune cells in retinas, dispose of axon debris through phagocytosis ( 67 – 70 ).”
Li, S.-M., Liu, H., Lv, P., Yao, Y., Peng, L., Xia, T., Yan, C., Ma, Z., Chen, Z., Zhao, C., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03216-2 · Cited by 55
“Multiple studies have revealed the importance of phagocytosis of microglial excitatory synapses, in the developing brain and the context of some neurodegenerative disorders [15, 17, 18].”
BackgroundSelf-citationNeuroinflammation — using big data to inform clinical practice
Dendrou, C. A., McVean, G., & Fugger, L. H. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.171 · Cited by 50
“The idea that aberrant synaptic pruning mediated by crosstalk between the complement system and microglia is involved in AD is also gaining momentum, supported by genetic associations 15 and functional follow-up investigations 20 .”
BackgroundWassouf, Z., Hentrich, T., Samer, S., Rotermund, C., Kahle, P. J., Ehrlich, I., Rieß, O., Casadei, N., & Schulze-Hentrich, J. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00112 · Cited by 44
Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics
Abreu, C. M., Soares-dos-Reis, R., Melo, P., Relvas, J., Guimarães, J., Sá, M., Cruz, A., & Pinto, I. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00164 · Cited by 36
“…and tumor necrosis factor α (TNFα)] and leading to synaptic loss, mitogen-activated protein kinase (MAPK) activation and subsequent NFTs formation (Griffin et al., 2006; Heneka et al., 2013; Dursun et al., 2015; Wang et al., 2015; Hong et al., 2016; Fonseca et al., 2017; Liddelow et al., 2017).”
BackgroundDiniz, L. P., Matias, I., Araujo, A. P. B., Garcia, M. N., Barros‐Aragão, F. G. Q., Alves‐Leon, S. V., de Souza, J. M., Foguel, D., Figueiredo, C. P., Braga, C., et al. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14710 · Cited by 41
“In animal models of Alzheimer’s disease, microglia directly contribute to the synaptic deficit observed in such conditions (Hong et al. 2016).”
BackgroundWang, C., Zhao, C., Liu, W., Huang, X., Deng, Y., Jiang, J., & Li, W. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2019.6460 · Cited by 40
“42,43 After TBI, apparent loss of dendrite spines has been observed both in the ipsilateral cortex and contralateral cortex.”
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01492-x · Cited by 41
“Additionally, multiple studies have shown that complement factor inhibition ameliorates synapse and neuron loss [90–93].”
Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury
Pekna, M., Stokowska, A., & Pekny, M. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03419-6 · Cited by 41
Neurochemical effects of sepsis on the brain
Barichello, T., Giridharan, V. V., Catalão, C. H. R., Ritter, C., & Dal‐Pizzol, F. (2023) · Clinical Science · doi:10.1042/cs20220549 · Cited by 49
Du, B., Zou, Q., Wang, X., Wang, H., Yang, X., Wang, Q., & Wang, K. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123403 · Cited by 53
Zhou, X. J., Chu, X., Xin, D., Li, T., Bai, X., Qiu, J., Yuan, H., Liu, D., Wang, D., & Wang, Z. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00058 · Cited by 40
Inflammation: A Major Target for Compounds to Control Alzheimer’s Disease
Maccioni, R. B., Navarrete, L. P., González, A., González-Canacer, A., Guzmán-Martínez, L., & Cortés, N. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-191014 · Cited by 40
Deep Brain Stimulation for Alzheimer’s Disease: Tackling Circuit Dysfunction
Lam, J., Lee, J., Liu, C. Y., Lozano, A. M., & Lee, D. J. (2020) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13305 · Cited by 46
“The latter finding was found to be dependent on Aβ oligomer-induced phagocytosis of synapses by microglia and rescued by complement or complement receptor inhibition (161).”
BackgroundScarante, F. F., Ribeiro, M. A., Almeida-Santos, A. F., Guimarães, F. S., & Campos, A. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618065 · Cited by 46
“Of note, the activation of glial cells during insults or neuropsychiatric conditions are not only a secondary response to damage, but could also play a pathophysiological role in its development (Jonsson et al., 2013; Hong et al., 2016; Sekar et al., 2016).”
BackgroundThe Emerging Role of Microglia in Neuromyelitis Optica
Chen, T., Bosco, D. B., Ying, Y., Tian, D., & Wu, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616301 · Cited by 46
“In addition, C3 signaling can also participate in neurodegeneration by activating microglial complement receptor 3 (CR3) (34, 103, 106, 107).”
Backgroundde Andrade, E. G., Šimončičová, E., Carrier, M., Vecchiarelli, H. A., Robert, M.-È., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.647378 · Cited by 41
A Comparative Biology of Microglia Across Species
Sharma, K. P., Bisht, K., & Eyo, U. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.652748 · Cited by 49
Neuroplastic Effect of Exercise Through Astrocytes Activation and Cellular Crosstalk
Li, F., Geng, X., Yun, H. J., Haddad, Y. W., Chen, Y., & Ding, Y. (2021) · Aging and Disease · doi:10.14336/ad.2021.0325 · Cited by 49
Deng, J., Feng, X., Zhou, L., He, C., Li, H., Xia, J., Ge, Y., Zhao, Y., Song, C., Chen, L., et al. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111576 · Cited by 44
Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology
Stym‐Popper, G., Matta, K., Chaigneau, T., Rupra, R., Demetriou, A., Fouquet, S., Dansokho, C., Toly‐Ndour, C., & Dorothée, G. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02702-3 · Cited by 49
“An increase in C1q secretion in the brain of AD-like mouse models has also been linked with neurotoxicity and synapse loss associated with amyloid deposition [28].”
BackgroundAfsar, A., Castro, M. D. C. C., Soladogun, A. S., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087258 · Cited by 49
Homer, B., Judd, J., Dehcheshmeh, M. M., Ebrahimie, E., & Trott, D. J. (2023) · Animals · doi:10.3390/ani13091458 · Cited by 42
Knowing the enemy: strategic targeting of complement to treat Alzheimer disease
Tenner, A. J., & Petrisko, T. J. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01073-y · Cited by 55
“Although regulated complement-mediated synaptic pruning is beneficial during development and adulthood, multiple studies have demonstrated the detrimental effect of excessive synaptic pruning in neurodegenerative diseases, including in mouse models of AD 87,96,106,118 .”
Molecular Bases of Alzheimer’s Disease and Neurodegeneration: The Role of Neuroglia
Luca, A., Calandra, C., & Luca, M. (2018) · Aging and disease · doi:10.14336/ad.2018.0201 · Cited by 39
“In AD, the presence of Aβ oligomers determines an aberrant activation of the complement cascade, even before plaque deposition [193].”
BackgroundSon, H., Kim, S., Jung, D.-H., Baek, J. H., Lee, D. H., Roh, G. S., Kang, S. S., Cho, G. J., Choi, W. S., Lee, D. K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36619-2 · Cited by 39
Cursano, S., Battaglia, C. R., Urrutia‐Ruiz, C., Grabrucker, S., Schön, M., Bockmann, J., Braumüller, S. T., Radermacher, P., Roselli, F., Huber-Lang, M. S., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0659-y · Cited by 41
Donnelly, K. M., DeLorenzo, O. R., Zaya, A., Pisano, G. E., Thu, W. M., Luo, L., Kopito, R. R., & Pearce, M. M. P. (2020) · eLife · doi:10.7554/elife.58499 · Cited by 42
Bhat, M. A., Ahmad, K., Khan, M. S., Bhat, M. A., Almatroudi, A., Rahman, S., & Jan, A. T. (2020) · Biomolecules · doi:10.3390/biom10060863 · Cited by 44
“The effect of synaptic LTP impairment and synaptotoxicity were prevented on administration of C1q neutralizing antibodies, and even in the C1q knockout mouse model [100,107].”
BackgroundPresenilin 1 phosphorylation regulates amyloid-β degradation by microglia
Ledo, J. H., Liebmann, T., Zhang, R., Chang, J. C., Azevedo, E. P., Wong, E., Silva, H. M., Troyanskaya, O. G., Bustos, V., & Greengard, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0856-8 · Cited by 39
Multifaceted Involvement of Microglia in Gray Matter Pathology in Multiple Sclerosis
Tsouki, F., & Williams, A. (2021) · Stem Cells · doi:10.1002/stem.3374 · Cited by 41
Irfan, M., Evonuk, K. S., & DeSilva, T. M. (2022) · The FEBS Journal · doi:10.1111/febs.16190 · Cited by 39
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
Pons, V., & Rivest, S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000400 · Cited by 43
“The synaptic loss is associated with the cognitive decline in AD, which may also depend on the complement cascade together with amyloid plaques (Hong et al., 2016).”
Backgroundvan der Ende, E. L., Heller, C., Sogorb‐Esteve, A., Swift, I. J., McFall, D. J., Peakman, G., Bouzigues, A., Poos, J. M., Jiskoot, L. C., Panman, J. L., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02573-0 · Cited by 41
“In AD mouse models, complement aggregation is observed prior to plaque formation [17, 18, 52].”
BackgroundClearing the Fog surrounding Chemobrain
Gutmann, D. H. (2019) · Cell · doi:10.1016/j.cell.2018.12.027 · Cited by 38
Synapse development is regulated by microglial THIK-1 K + channels
Izquierdo, P., Shiina, H., Hirunpattarasilp, C., Gillis, G., & Attwell, D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106294118 · Cited by 38
Yao, X., Yang, C., Wang, C., Li, H., Zhao, J., Kang, X., Liu, Z., Chen, L., Chen, X., Pu, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158316 · Cited by 39
Macrophages regulate gastrointestinal motility through complement component 1q
Pendse, M., Selle, H. D., Vo, N., Quinn, G. M., Dende, C., Li, Y., Salinas, C. N., Srinivasan, T., Propheter, D. C., Crofts, A. A., et al. (2023) · eLife · doi:10.7554/elife.78558 · Cited by 39
“C1q is also produced by microglia (brain-resident macrophage-like cells) in the brain where it promotes the pruning of neuronal synapses through an unclear mechanism (Hammond et al., 2020; Hong et al., 2016).”
BackgroundDevelopment of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer’s Disease
Saetzler, V., Riët, T., Schienke, A., Henschel, P., Freitag, K., Haake, A. F. H., Heppner, F. L., Buitrago‐Molina, L. E., Noyan, F., Jaeckel, E., et al. (2023) · Cells · doi:10.3390/cells12162115 · Cited by 43
Luan, Y., Wang, W., Huang, Q., Wang, Y., Nussbaumer, J., Wang, J., Steward, A., Roemer, S. N., Guan, Y., Ewers, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61497-4 · Cited by 51
“This ultimately leads to more severe and widespread synaptic loss rather than the localized loss surrounding individual plaques 28 .”
Differential effect of angiotensin II and blood pressure on hippocampal inflammation in mice
Iulita, M. F., Vallerand, D., Beauvillier, M., Haupert, N., Ulysse, C. A., Gagné, A., Vernoux, N., Duchemin, S., Boily, M., Tremblay, M., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1090-z · Cited by 41
“disease animal models, contributing to synaptic loss, which is a strong correlate of cognitive decline [46].”
Cerebrovascular inflammation: A critical trigger for neurovascular injury?
Naveed, M., Zhou, Q., & Han, F. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.011 · Cited by 38
The role of microglia in ischemic preconditioning
McDonough, A., & Weinstein, J. R. (2019) · Glia · doi:10.1002/glia.23695 · Cited by 40
“However, aberrant responses to complement, or excessive accumulations of complement proteins, may be contributing factors to neurological diseases such as AD (Hong et al., 2016) and multiple sclerosis (MS) (Michailidou et al., 2016).”
BackgroundInfluentialJuul-Madsen, K., Qvist, P., Bendtsen, K. L., Langkilde, A. E., Vestergaard, B., Howard, K. A., Dehesa-Etxebeste, M., Paludan, S. R., Andersen, G. R., Jensen, P. H., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900494 · Cited by 37
The dialog between neurons and microglia in Alzheimer's disease: The neurotransmitters view
Stolero, N., & Frenkel, D. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15262 · Cited by 39
“They have also been reported to be involved in complement activity in AD and mediate synapse loss (Dejanovic et al., 2018; Hong et al., 2016; Nizami et al., 2019).”
BackgroundNagy, D., Ennis, K. A., Wei, R., Su, S. C., Hinckley, C. A., Gu, R.-F., Gao, B., Massol, R., Ehrenfels, C., Jandreski, L., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2001679118 · Cited by 39
“For example, in an AD model, synapse elimination was shown to be mediated by the complement pathway in the hippocampus (HC), reflecting aberrant reactivation of complement-dependent synapse elimination that occurs in the dorsal lateral geniculate nucleus (dLGN) of the thalamus during visual development (4).”
Sun, T., Shi, Q., Zhang, Y., Power, C., Hoesch, C., Antonelli, S., Schroeder, M. K., Caldarone, B. J., Taudte, N., Schenk, M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.037 · Cited by 42
Self-citationAmyloid Prefibrillar Oligomers: The Surprising Commonalities in Their Structure and Activity
Diociaiuti, M., Bonanni, R., Cariati, I., Frank, C., & D’Arcangelo, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126435 · Cited by 42
Lin, Y., Shi, Q., Zhang, L., Yue, C.-P., He, Z.-J., Li, X.-X., He, Q., Liu, Q., & Du, X. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.317992 · Cited by 41
“Aβ oligomers, phosphorylated tau, and oxidative stress all contribute to synaptic deficits, which are regarded as an early event of AD (Hong et al., 2016; Forner et al., 2017; Batista et al., 2018; Rice et al., 2019).”
Self-citationWu, J., Zhu, Y., Zhou, L., Yang, L., Feng, T., Dai, M., Liu, J., Xu, W., Cheng, W., Sun, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.710513 · Cited by 42
“This may result in the release of bacterial LPS into the bloodstream, thereby leading to endotoxemia and systemic inflammation, which eventually lead to cognitive decline (5, 52).”
BackgroundWhole-exome sequencing associates novelCSMD1gene mutations with familial Parkinson disease
Ruiz-Martínez, J., Azcona, L. J., Bergareche, A., Martí-Massó, J. F., & Paisán‐Ruiz, C. (2017) · Neurology Genetics · doi:10.1212/nxg.0000000000000177 · Cited by 41
“In particular, based on mice models of AD, it can be said that both the microglia and the component pathway might act as early mediators of hippocampal synapse loss and dysfunction before plaque formation and neuroinflammation.(32) In addition, copy number variations within the CSMD1 locus have been reported in patien…”
Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy
LeBlang, C. J., Medalla, M., Nicoletti, N. W., Hays, E. C., Zhao, J., Shattuck, J. E., Cruz, A. L., Wolozin, B. L., & Luebke, J. I. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00285 · Cited by 43
Tang, J., Jila, S., Luo, T., Zhang, B., Miao, H., Feng, H., Chen, Z., & Zhu, G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108927 · Cited by 39
Synapses, Microglia, and Lipids in Alzheimer’s Disease
Paasila, P. J., Aramideh, J. A., Sutherland, G. T., & Graeber, M. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.778822 · Cited by 47
“, 2021), a scenario that has been also observed in human mutant APP mice (J20) (Hong et al., 2016).”
BackgroundGao, C., Shen, X., Tan, Y., & Chen, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02580-1 · Cited by 52
“Microglia recognize the "eat me" signal, and microglial complement receptor CR3 binds to neuronal C3, promoting synapse engulfment by microglia [73, 175, 176].”
BackgroundSun, X., Yu, X., Zhu, J., Li, L.-J., Zhang, L., Huang, Y., Liu, D., Ji, M., Sun, X., Zhang, L. L., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01273-8 · Cited by 52
“In the progress of AD, oligomeric β-amyloid (Aβ) prefers to bind to synapses, triggers microglia to excessively eliminate synapses via complement-dependent pathway, which contributes to synapse loss and cognitive deficits.(8,9) To attenuate the deleterious effects of Aβ, immunotherapy, one of the most promising interv…”
BackgroundImmune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases
Poppell, M., Hammel, G., & Ren, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065925 · Cited by 42
Kodali, M., Madhu, L. N., Reger, R. L., Milutinovic, B. S., Upadhya, R., Attaluri, S., Shuai, B., Shankar, G., & Shetty, A. K. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1185883 · Cited by 41
Ou, Z., Zhao, M., Xu, Y. X., Wu, Y., Qin, L., Li, F., Xu, H., & Chen, J. (2023) · Aging · doi:10.18632/aging.204989 · Cited by 46
Yao, X., Yang, C., Jia, X., Yu, Z., Wang, C., Zhao, J., Chen, Y., Xie, B., Zhuang, H., Sun, C., et al. (2024) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2024.04.005 · Cited by 38
Extracellular Vesicle-Mediated Neuron–Glia Communications in the Central Nervous System
Ikezu, T., Yang, Y., Verderio, C., & Krämer‐Albers, E. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1170-24.2024 · Cited by 55
(Re)building the nervous system: A review of neuron–glia interactions from development to disease
Demmings, M. D., Chagas, L. D. S., Traetta, M. E., Rodrigues, R. S., Acutain, M. F., Barykin, E. P., Datusalia, A. K., German‐Castelan, L., Mattera, V. S., Mazengenya, P., et al. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16258 · Cited by 49
“Finally, activation of the complement system within microglia contributes to synapse loss in AD (Hong et al., 2016 ) and damaged dopaminergic neurons can activate the microglial complement receptor C3aR to produce increased complement C1q which may contribute to synaptic abnormalities and…”
Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3
Jensen, M. R., Bajic, G., Zhang, X., Laustsen, A. K., Koldsø, H., Skeby, K. K., Schiøtt, B., Andersen, G. R., & Vorup‐Jensen, T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.732222 · Cited by 35
Walsh, C., Drinkenburg, W. H. I. M., & Ahnaou, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.020 · Cited by 39
Inflammation as a Possible Link Between Dyslipidemia and Alzheimer’s Disease
Oliveira, B. C. D. L., Bellozi, P. M. Q., Reis, H. J., & de Oliveira, A. C. P. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.012 · Cited by 44
Complement Activation in Capillary Cerebral Amyloid Angiopathy
Matsuo, K., Shindo, A., Niwa, A., Tabei, K.-I., Akatsu, H., Hashizume, Y., Akiyama, H., Ayaki, T., Maki, T., Sawamoto, N., et al. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000486091 · Cited by 37
Sekiya, M., Wang, M., Fujisaki, N., Sakakibara, Y., Quan, X., Ehrlich, M. E., De Jager, P. L., Bennett, D. A., Schadt, E. E., Gandy, S., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0530-9 · Cited by 38
“Microglia in adult brains engulf spines and other synaptic processes; exposure to Aβ may inappropriately activate this process to mediate synapse loss [35].”
BackgroundDevelopmental Coordination during Olfactory Circuit Remodeling in Drosophila
Mayseless, O., Berns, D. S., Yu, X. M., Riemensperger, T., Fiala, A., & Schuldiner, O. (2018) · Neuron · doi:10.1016/j.neuron.2018.07.050 · Cited by 36
Deciphering microbiome and neuroactive immune gene interactions in schizophrenia
Severance, E. G., & Yolken, R. H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.016 · Cited by 37
Lee, A. S., Rusch, J., Lima, A. C., Usmani, A., Huang, N., Lepamets, M., Vigh‐Conrad, K. A., Worthington, R. E., Mägi, R., Wu, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12522-w · Cited by 47
Nareshkumar, A., Subbarao, S., Vennapusa, A. R., Vargheese, A., Banarjee, R., Kulkarni, M. J., Vemanna, R. S., & Udayakumar, M. (2020) · Journal of Plant Growth Regulation · doi:10.1007/s00344-020-10072-w · Cited by 37
If Human Brain Organoids Are the Answer to Understanding Dementia, What Are the Questions?
Ooi, L., Dottori, M., Cook, A. L., Engel, M., Gautam, V., Grubman, A., Hernández, D., King, A. E., Maksour, S., Anastacio, H. T. D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420912404 · Cited by 35
Peli1 impairs microglial Aβ phagocytosis through promoting C/EBPβ degradation
Xu, J., Yu, T., Pietronigro, E. C., Yuan, J., Arioli, J., Pei, Y., Luo, X., Ye, J., Constantin, G., Mao, C., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000837 · Cited by 38
Non-cell autonomous astrocyte-mediated neuronal toxicity in prion diseases
Kushwaha, R., Sinha, A., Makarava, N., Molesworth, K., & Baskakov, I. V. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01123-8 · Cited by 42
Sokolova, D., Childs, T., & Hong, S. Y. (2021) · Faculty Reviews · doi:10.12703/r/10-19 · Cited by 39
Self-citationDe Sousa, V. L., Araújo, S. B., Antonio, L. M., Silva-Queiroz, M., Colodeti, L. C., Soares, C., Barros-Aragão, F., Mota-Araujo, H. P., Alves, V. S., Coutinho-Silva, R., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.04.001 · Cited by 37
Qiu, W., Luo, S., Ma, S. A., Saminathan, P., Li, H., Gunnersen, J. M., Gelbard, H. A., & Hammond, J. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.607641 · Cited by 47
Sanchez-Varo, R. M., Sánchez‐Mejías, E., Fernandez-Valenzuela, J. J., Castro, V. D., Mejias‐Ortega, M., Gómez-Arboledas, Á., Jiménez, S., Sanchez-Mico, M. V., Trujillo‐Estrada, L., Moreno‐González, I., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.752594 · Cited by 44
László, Z. I., Hindley, N., Avila, A. S., Kline, R., Eaton, S. L., Lamont, D. J., Smith, C., Spires‐Jones, T. L., Wishart, T. M., & Henstridge, C. M. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01455-z · Cited by 41
“This has recently been shown to be a driver of Alzheimer’s disease pathogenesis [56] and our data revealing increased expression of several complement proteins at the ALS synapse, may suggest a similar process renders ALS synapses vulnerable to aberrant removal.”
BackgroundMcKee, C., Hoffos, M., Vecchiarelli, H. A., & Tremblay, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125982 · Cited by 40
Fekete, C., Vastagh, C., Dénes, Á., Hrabovszky, E., Nyíri, G., Kalló, I., Liposits, Z., & Sárvári, M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.046 · Cited by 43
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.